Intranasal immunization with nontypeable Haemophilus influenzae outer membrane vesicles induces cross-protective immunity in mice

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Roier, Sandro ^a   Leitner, Deborah R ^a   Iwashkiw, Jeremy ^b   Schild Prüfert, Kristina ^a   Feldman, Mario F ^b   Krohne, Georg ^c   Reidl, Joachim ^a   Schild, Stefan ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; HAEMOPHILUS INFLUENZAE VACCINE; HEME BINDING PROTEIN A; HEME UTILIZATION PROTEIN; OUTER MEMBRANE PROTEIN P1; OUTER MEMBRANE PROTEIN P2; OUTER MEMBRANE PROTEIN P5; OUTER MEMBRANE PROTEIN P6; PROTECTIVE SURFACE ANTIGEN D15; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; CONTROLLED STUDY; CROSS PROTECTION; FEMALE; HAEMOPHILUS INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MEMBRANE VESICLE; MOUSE; MUCOSAL IMMUNITY; NASOPHARYNX; NONHUMAN;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CELL MEMBRANE STRUCTURES; CROSS PROTECTION; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; IMMUNITY; IMMUNITY, HUMORAL; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOPRECIPITATION; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; NASOPHARYNX; SPECIES SPECIFICITY; TIME FACTORS; VIBRIO CHOLERAE;

BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE; MUS; NEGIBACTERIA; OAT MOSAIC VIRUS;

EID: 84864569736     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042664     Document Type: Article

References (98)

1. Erwin AL, Smith AL, (2007) Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior. Trends Microbiol 15: 355-362.
2. Johnston JW, Apicella MA (2009) Haemophilus influenzae. In: Schaechter M, editor. Encyclopedia of Microbiology, 3rd ed. Amsterdam: Academic Press, Elsevier Ltd.153-162.
3. Rao VK, Krasan GP, Hendrixson DR, Dawid S, St Geme JW 3rd, (1999) Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae. FEMS Microbiol Rev 23: 99-129.
4. Murphy TF, (2006) The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis 19: 225-230.
5. Sethi S, Murphy TF, (2001) Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 14: 336-363.
6. WHO (2008) World health statistics 2008. Geneva, Switzerland: World Health Organization. Available: http://www.who.int/gho/publications/world_health_statistics/EN_WHS08_Full.pdf. Accessed 2012 Jul 14.
7. Morris SK, Moss WJ, Halsey N, (2008) Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect Dis 8: 435-443.
8. Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, et al. (2010) Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine 28: 4073-4078.
9. Dworkin MS, Park L, Borchardt SM, (2007) The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons> or = 65 years old. Clin Infect Dis 44: 810-816.
10. Tsang RS, Sill ML, Skinner SJ, Law DK, Zhou J, et al. (2007) Characterization of invasive Haemophilus influenzae disease in Manitoba, Canada, 2000-2006: invasive disease due to non-type b strains. Clin Infect Dis 44: 1611-1614.
11. Ulanova M, Tsang RS, (2009) Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century. Infect Genet Evol 9: 594-605.
12. van Alphen L, Caugant DA, Duim B, O'Rourke M, Bowler LD, (1997) Differences in genetic diversity of nonecapsulated Haemophilus influenzae from various diseases. Microbiology 143: 1423-1431.
13. Poolman JT, Bakaletz L, Cripps A, Denoel PA, Forsgren A, et al. (2000) Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine 19 (Suppl 1): S108-S115.
14. Ostberg KL, Russell MW, Murphy TF, (2009) Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae. Mucosal Immunol 2: 63-73.
15. Hotomi M, Ikeda Y, Suzumoto M, Yamauchi K, Green BA, et al. (2005) A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization. Vaccine 23: 1294-1300.
16. Murphy TF, Kirkham C, Lesse AJ, (2006) Construction of a mutant and characterization of the role of the vaccine antigen P6 in outer membrane integrity of nontypeable Haemophilus influenzae. Infect Immun 74: 5169-5176.
17. Murphy TF, (2009) Current and future prospects for a vaccine for nontypeable Haemophilus influenzae. Curr Infect Dis Rep 11: 177-182.
18. Singh B, Brant M, Kilian M, Hallstrom B, Riesbeck K, (2010) Protein E of Haemophilus influenzae is a ubiquitous highly conserved adhesin. J Infect Dis 201: 414-419.
19. Hirano T, Hou Y, Jiao X, Gu XX, (2003) Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx. FEMS Immunol Med Microbiol 35: 1-10.
20. Wu T, Chen J, Murphy TF, Green BA, Gu XX, (2005) Investigation of non-typeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines. Vaccine 23: 5177-5185.
21. Gu XX, Tsai CM, Ueyama T, Barenkamp SJ, Robbins JB, et al. (1996) Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins. Infect Immun 64: 4047-4053.
22. Chang A, Kaur R, Michel LV, Casey JR, Pichichero M, (2011) Haemophilus influenzae vaccine candidate outer membrane protein P6 is not conserved in all strains. Hum Vaccin 7: 102-105.
23. Michel LV, Kalmeta B, McCreary M, Snyder J, Craig P, et al. (2011) Vaccine candidate P6 of nontypable Haemophilus influenzae is not a transmembrane protein based on protein structural analysis. Vaccine 29: 1624-1627.
24. Beveridge TJ, (1999) Structures of gram-negative cell walls and their derived membrane vesicles. J Bacteriol 181: 4725-4733.
25. Ellis TN, Kuehn MJ, (2010) Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev 74: 81-94.
26. Mashburn-Warren LM, Whiteley M, (2006) Special delivery: vesicle trafficking in prokaryotes. Mol Microbiol 61: 839-846.
27. Kulp A, Kuehn MJ, (2010) Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol 64: 163-184.
28. Gankema H, Wensink J, Guinee PA, Jansen WH, Witholt B, (1980) Some characteristics of the outer membrane material released by growing enterotoxigenic Escherichia coli. Infect Immun 29: 704-713.
29. Hoekstra D, van der Laan JW, de Leij L, Witholt B, (1976) Release of outer membrane fragments from normally growing Escherichia coli. Biochim Biophys Acta 455: 889-899.
30. Post DM, Zhang D, Eastvold JS, Teghanemt A, Gibson BW, et al. (2005) Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B. J Biol Chem 280: 38383-38394.
31. Kim SH, Kim KS, Lee SR, Kim E, Kim MS, et al. (2009) Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles. Biochim Biophys Acta 1788: 2150-2159.
32. Bishop AL, Schild S, Patimalla B, Klein B, Camilli A, (2010) Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility. Infect Immun 78: 4402-4420.
33. Holst J, Martin D, Arnold R, Huergo CC, Oster P, et al. (2009) Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 27 (Suppl 2): B3-B12.
34. Schild S, Nelson EJ, Camilli A, (2008) Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect Immun 76: 4554-4563.
35. Schild S, Nelson EJ, Bishop AL, Camilli A, (2009) Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. Infect Immun 77: 472-484.
36. Alaniz RC, Deatherage BL, Lara JC, Cookson BT, (2007) Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol 179: 7692-7701.
37. Whitmire WM, Garon CF, (1993) Specific and nonspecific responses of murine B cells to membrane blebs of Borrelia burgdorferi. Infect Immun 61: 1460-1467.
38. Roberts R, Moreno G, Bottero D, Gaillard ME, Fingermann M, et al. (2008) Outer membrane vesicles as acellular vaccine against pertussis. Vaccine 26: 4639-4646.
39. Kesavalu L, Ebersole JL, Machen RL, Holt SC, (1992) Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infect Immun 60: 1455-1464.
40. Sexton K, Lennon D, Oster P, Crengle S, Martin D, et al. (2004) The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic. N Z Med J 117: U1015.
41. Deich RA, Hoyer LC, (1982) Generation and release of DNA-binding vesicles by Haemophilus influenzae during induction and loss of competence. J Bacteriol 152: 855-864.
42. Concino MF, Goodgal SH, (1982) DNA-binding vesicles released from the surface of a competence-deficient mutant of Haemophilus influenzae. J Bacteriol 152: 441-450.
43. Hong W, Pang B, West-Barnette S, Swords WE, (2007) Phosphorylcholine expression by nontypeable Haemophilus influenzae correlates with maturation of biofilm communities in vitro and in vivo. J Bacteriol 189: 8300-8307.
44. Sharpe SW, Kuehn MJ, Mason KM, (2011) Elicitation of epithelial cell-derived immune effectors by outer membrane vesicles of nontypeable Haemophilus influenzae. Infect Immun 79: 4361-4369.
45. Schild S, Tamayo R, Nelson EJ, Qadri F, Calderwood SB, et al. (2007) Genes induced late in infection increase fitness of Vibrio cholerae after release into the environment. Cell Host Microbe 2: 264-277.
46. Murphy TF, Apicella MA, (1985) Antigenic heterogeneity of outer membrane proteins of nontypable Haemophilus influenzae is a basis for a serotyping system. Infect Immun 50: 15-21.
47. Meats E, Feil EJ, Stringer S, Cody AJ, Goldstein R, et al. (2003) Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol 41: 1623-1636.
48. Carlone GM, Thomas ML, Rumschlag HS, Sottnek FO, (1986) Rapid microprocedure for isolating detergent-insoluble outer membrane proteins from Haemophilus species. J Clin Microbiol 24: 330-332.
49. Campagnari AA, Gupta MR, Dudas KC, Murphy TF, Apicella MA, (1987) Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae. Infect Immun 55: 882-887.
50. Gaucher SP, Cancilla MT, Phillips NJ, Gibson BW, Leary JA, (2000) Mass spectral characterization of lipooligosaccharides from Haemophilus influenzae 2019. Biochemistry 39: 12406-12414.
51. Phillips NJ, Apicella MA, Griffiss JM, Gibson BW, (1992) Structural characterization of the cell surface lipooligosaccharides from a nontypable strain of Haemophilus influenzae. Biochemistry 31: 4515-4526.
52. Engskog MK, Deadman M, Li J, Hood DW, Schweda EK, (2011) Detailed structural features of lipopolysaccharide glycoforms in nontypeable Haemophilus influenzae strain 2019. Carbohydr Res 346: 1241-1249.
53. Pang B, Winn D, Johnson R, Hong W, West-Barnette S, et al. (2008) Lipooligosaccharides containing phosphorylcholine delay pulmonary clearance of nontypeable Haemophilus influenzae. Infect Immun 76: 2037-2043.
54. Tong HH, Blue LE, James MA, Chen YP, DeMaria TF, (2000) Evaluation of phase variation of nontypeable Haemophilus influenzae lipooligosaccharide during nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun 68: 4593-4597.
55. Rahman MM, Gu XX, Tsai CM, Kolli VS, Carlson RW, (1999) The structural heterogeneity of the lipooligosaccharide (LOS) expressed by pathogenic non-typeable Haemophilus influenzae strain NTHi 9274. Glycobiology 9: 1371-1380.
56. Dalseg R, Wedege E, Holst J, Haugen IL, Hoiby EA, et al. (1999) Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice. Vaccine 17: 2336-2345.
57. Saunders NB, Shoemaker DR, Brandt BL, Moran EE, Larsen T, et al. (1999) Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice. Infect Immun 67: 113-119.
58. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
59. Kang D, Gho YS, Suh M, Kang C, (2002) Highly sensitive and fast protein detection with coomassie brilliant blue in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Bull Kor Chem Soc 23: 1511-1512.
60. Shevchenko A, Wilm M, Vorm O, Mann M, (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858.
61. Gu XX, Rudy SF, Chu C, McCullagh L, Kim HN, et al. (2003) Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae. Vaccine 21: 2107-2114.
62. Hong W, Peng D, Rivera M, Gu XX, (2010) Protection against nontypeable Haemophilus influenzae challenges by mucosal vaccination with a detoxified lipooligosaccharide conjugate in two chinchilla models. Microbes Infect 12: 11-18.
63. Gu XX, Sun J, Jin S, Barenkamp SJ, Lim DJ, et al. (1997) Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas. Infect Immun 65: 4488-4493.
64. Bauman SJ, Kuehn MJ, (2006) Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response. Microbes Infect 8: 2400-2408.
65. Haurat MF, Aduse-Opoku J, Rangarajan M, Dorobantu L, Gray MR, et al. (2011) Selective sorting of cargo proteins into bacterial membrane vesicles. J Biol Chem 286: 1269-1276.
66. Olofsson A, Vallstrom A, Petzold K, Tegtmeyer N, Schleucher J, et al. (2010) Biochemical and functional characterization of Helicobacter pylori vesicles. Mol Microbiol 77: 1539-1555.
67. Kato S, Kowashi Y, Demuth DR, (2002) Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin. Microb Pathog 32: 1-13.
68. Wensink J, Witholt B, (1981) Outer-membrane vesicles released by normally growing Escherichia coli contain very little lipoprotein. Eur J Biochem 116: 331-335.
69. Barenkamp SJ, Munson RS Jr, Granoff DM, (1982) Outer membrane protein and biotype analysis of pathogenic nontypable Haemophilus influenzae. Infect Immun 36: 535-540.
70. Groeneveld K, van Alphen L, Eijk PP, Jansen HM, Zanen HC, (1988) Changes in outer membrane proteins of nontypable Haemophilus influenzae in patients with chronic obstructive pulmonary disease. J Infect Dis 158: 360-365.
71. Groeneveld K, van Alphen L, Voorter C, Eijk PP, Jansen HM, et al. (1989) Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease. Infect Immun 57: 3038-3044.
72. Loos BG, Bernstein JM, Dryja DM, Murphy TF, Dickinson DP, (1989) Determination of the epidemiology and transmission of nontypable Haemophilus influenzae in children with otitis media by comparison of total genomic DNA restriction fingerprints. Infect Immun 57: 2751-2757.
73. Murphy TF, Dudas KC, Mylotte JM, Apicella MA, (1983) A subtyping system for nontypable Haemophilus influenzae based on outer-membrane proteins. J Infect Dis 147: 838-846.
74. Spinola SM, Peacock J, Denny FW, Smith DL, Cannon JG, (1986) Epidemiology of colonization by nontypable Haemophilus influenzae in children: a longitudinal study. J Infect Dis 154: 100-109.
75. Ogra PL, Bernstein JM, Yurchak AM, Coppola PR, Tomasi TB Jr, (1974) Characteristics of secretory immune system in human middle ear: implications in otitis media. J Immunol 112: 488-495.
76. Sloyer JL Jr, Howie VM, Ploussard JH, Schiffman G, Johnston RB Jr, (1976) Immune response to acute otitis media: association between middle ear fluid antibody and the clearing of clinical infection. J Clin Microbiol 4: 306-308.
77. McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, et al. (1992) The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10: 75-88.
78. Mestecky J, McGhee JR, (1992) Prospects for human mucosal vaccines. Adv Exp Med Biol 327: 13-23.
79. Belyakov IM, Ahlers JD, (2009) What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? J Immunol 183: 6883-6892.
80. Holmgren J, Czerkinsky C, (2005) Mucosal immunity and vaccines. Nat Med 11: S45-53.
81. Kiyono H, Fukuyama S, (2004) NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 4: 699-710.
82. Avrameas S, (1991) Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today 12: 154-159.
83. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, et al. (1999) Control of early viral and bacterial distribution and disease by natural antibodies. Science 286: 2156-2159.
84. Bertot GM, Becker PD, Guzman CA, Grinstein S, (2004) Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae. J Infect Dis 189: 1304-1312.
85. Hirano T, Jiao X, Chen Z, Van Waes C, Gu XX, (2006) Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine. Immunol Lett 107: 131-139.
86. Vetvik H, Grewal HM, Haugen IL, Ahren C, Haneberg B, (1998) Mucosal antibodies can be measured in air-dried samples of saliva and feces. J Immunol Methods 215: 163-172.
87. McConnell MJ, Rumbo C, Bou G, Pachon J, (2011) Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 29: 5705-5710.
88. Morton DJ, Madore LL, Smith A, Vanwagoner TM, Seale TW, et al. (2005) The heme-binding lipoprotein (HbpA) of Haemophilus influenzae: role in heme utilization. FEMS Microbiol Lett 253: 193-199.
89. Morton DJ, Seale TW, Bakaletz LO, Jurcisek JA, Smith A, et al. (2009) The heme-binding protein (HbpA) of Haemophilus influenzae as a virulence determinant. Int J Med Microbiol 299: 479-488.
90. Morton DJ, Smith A, Ren Z, Madore LL, VanWagoner TM, et al. (2004) Identification of a haem-utilization protein (Hup) in Haemophilus influenzae. Microbiology 150: 3923-3933.
91. Loosmore SM, Yang YP, Coleman DC, Shortreed JM, England DM, et al. (1997) Outer membrane protein D15 is conserved among Haemophilus influenzae species and may represent a universal protective antigen against invasive disease. Infect Immun 65: 3701-3707.
92. Bolduc GR, Bouchet V, Jiang RZ, Geisselsoder J, Truong-Bolduc QC, et al. (2000) Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach. Infect Immun 68: 4505-4517.
93. Novotny LA, Partida-Sanchez S, Munson RS Jr, Bakaletz LO, (2008) Differential uptake and processing of a Haemophilus influenzae P5-derived immunogen by chinchilla dendritic cells. Infect Immun 76: 967-977.
94. Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, et al. (2005) CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A 102: 4848-4853.
95. Malley R, Anderson PW, (2012) Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity. Proc Natl Acad Sci U S A 109: 3623-3627.
96. Mason KW, Zhu D, Scheuer CA, McMichael JC, Zlotnick GW, et al. (2004) Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529. Vaccine 22: 3449-3456.
97. Shurin PA, Pelton SI, Tager IB, Kasper DL, (1980) Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae. J Pediatr 97: 364-369.
98. Faden H, Bernstein J, Brodsky L, Stanievich J, Krystofik D, et al. (1989) Otitis media in children. I. The systemic immune response to nontypable Haemophilus influenzae. J Infect Dis 160: 999-1004.